The simple answer to high cost healthcare is government price controls. Problem is that this approach will always create health care shortages (see Medicare for all Canada) It may be counterintuitive, but if you want lower costs AND expanded access, don’t arbitrarily limit

As usual the good professor kills! Great work Ge Bai

Outstanding op-ed by Ge Bai STAT Price regulation dictates how care is delivered now and in the future, in ways that no one - especially those setting the prices - can anticipate. It will forever be a drag on health if we continue to let it. statnews.com/2024/08/30/hea…

My latest Forbes: Mr. Trump, We Should Fund Patients, Not The System, For IVF Treatments Johns Hopkins Carey Business School Johns Hopkins Bloomberg School of Public Health BSPH / HPM Johns Hopkins University forbes.com/sites/gebai/20…

Excited that Ge (and her coauthors) are tackling these questions. Stark (and anti kick back laws) increasingly hurt independent physicians, make primary care non viable, increase drug costs and generally make healthcare more complex leading to increased prices and reduced access,

Ge Bai Health Affairs Sunjay Letchuman Add enabling nonprofit status to apply to these health systems and allowing student loan forgiveness for their employed physicians (massive recruitment edge) and not for private practice physicians despite the nonprofit being able to bill significantly higher amounts.

“For all products and services, including healthcare, the best way to reduce prices, stimulate innovation, and benefit consumers is through free market competition. Wrong policies, such as funding providers or mandating insurance coverage, will inevitably fail patients. Mr.

When even Stark (yes, the namesake) wants Stark law repealed. You can’t make this stuff up.

This is a fantastic piece. Excellent work Professor Bai. Health Market and Policy Network Paragon Health Institute

Please join us on 9/11 for 2024 Symposium on Health Policy Johns Hopkins University Bloomberg Center (555 Penn, DC). Open to all. Free registration: carey.jhu.edu/events/2024-sy… U.S. Senator Bill Cassidy, M.D. Congressman Kevin Hern theo merkel Chapin White Joe Antos The Independent with Scott Atlas Brian Blase Michael F. Cannon 🇮🇪🇺🇸 Patrick James Dumas Grace G.

Unfortunately, I’ll be out of the country and won’t be able to attend, but I highly recommend this very interesting conference to those who can make it! 👇🏼

Many thanks to Benjamin Schwartz, MD, MBA for featuring my work: thesurgeonsrecord.substack.com/?utm_source=na… A double helping of health policy smackdowns from Professor Ge Bai The conundrum of health care price regulation (STAT; statnews.com/2024/08/30/hea…) This first piece highlights what many have long

My comments AIS Health: GoodRx to Offer Humira Biosimilar, but Can Patients Afford Cash Price? GoodRx, Inc. has dipped its toes into the booming Humira (adalimumab) biosimilar market with the help of Boehringer Ingelheim (BI), which will offer patients its Cyltezo

Thank you Ge Bai for all the work you do highlighting these important issues and not being afraid to challenge conventional wisdom with facts and well-reasoned arguments.

Full text of my article Forbes: Americans To Receive ‘Free’ Covid-19 Tests Again, But Are They Really Free? The Biden Administration announced that, starting in September, each U.S. household can order four Covid-19 test kits, mailed to homes free of charge. But are these

ICYMI, Ge Bai authored a powerhouse op-ed in @STATNEWS arguing that price regulation in #healthcare is a "dead end," while promoting competition will be the only way to control prices. Simply fantastic. #FAHayek would be proud. drugch.nl/3TcNtuy

Volunteers Needed for Our DC event on Sept 11 If you are available and willing to help for the whole day or half a day, please email [email protected]. Thank you all for your support of our symposium! Johns Hopkins Carey Business School Johns Hopkins University Bloomberg Center